The MicroByte Series-Saccharomyces boulardii: The First Yeast Probiotic

Jul 09, 2025

•

4 min read

•

First identified in 1920, Saccharomyces boulardii is a versatile probiotic yeast capable of supporting a wide array of human health functions. Driven by an advanced arsenal of antimicrobial compounds and serine proteases, it effortlessly modulates host immunity, spreading rapidly through oral supplementation and active food substrates. Clinical benefits range from minor digestive conditions like lactose intolerance to severe systemic complications, including giardiasis and life-threatening sepsis. Accurate identification leverages classic laboratory cultures and modern tools like strain-specific genomic sequencing. While optimization typically requires targeted probiotic therapy for strains like CNCM I-745, robust industrial application relies heavily on starter culture validation and dairy processing stability.

History

Saccharomyces boulardii is a unique, non-pathogenic yeast that has been widely used in Europe for the treatment of diarrhoea. It was discovered in 1920 by French microbiologist Henri Boulard during his visit to Indochina amid a cholera outbreak. Boulard observed that some individuals who remained unaffected by cholera were drinking tea made from the boiled skins of tropical fruits such as lychee and mangosteen. Intrigued by this, he successfully isolated the active agent from the tea, which turned out to be a distinct strain of yeast. He named it Saccharomyces boulardii. Originally isolated from lychee fruit, this probiotic yeast is now widely available across various continents, including South America, Europe, and Africa.

Non-pathogenic yeast- A completely safe, harmless type of microscopic fungus that does not cause disease or illness when it grows in or on the body.

Probiotic- Live, beneficial microorganisms (like good bacteria or friendly yeasts) that provide documented health advantages when consumed in proper amounts.

Health Benefits

S. boulardii is used in the treatment of various conditions and diseases, including acute pediatric diarrhoea, antibiotic-associated diarrhoea, Helicobacter pylori infections, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), traveller’s diarrhoea, acute adult diarrhoea, enteral nutrition-related diarrhoea, Clostridium difficile infections, necrotizing enterocolitis, HIV-related diarrhoea, giardiasis, sepsis, acne, and liver (hepatic) dysfunction.

Helicobacter pylori infections- Bacterial infections in the stomach that can weaken its protective lining, often leading to painful sores (ulcers) or chronic indigestion.

Enteral nutrition-related diarrhoea- Loose, watery stools that sometimes happen as a side effect when a patient receives liquid food through a medical feeding tube.

Necrotizing enterocolitis- A severe, dangerous medical condition where the tissue inside a newborn baby's intestines becomes inflamed and starts to break down or die.

Giardiasis- An intestinal infection caused by a microscopic parasite (Giardia), usually picked up from contaminated water, leading to cramps, gas, and watery diarrhea.

Sepsis- A life-threatening medical emergency triggered by the body’s extreme, runaway immune response to an infection, which can cause widespread organ damage.

Antimicrobial Activity

Saccharomyces boulardii competes with harmful bacteria for nutrients and space, thereby reducing their ability to grow. It also lowers the pH of the gut by producing acids such as acetic acid, creating an inhospitable environment for pathogens. Additionally, it releases specific proteins and enzymes that block or break down toxins produced by harmful microbes like Clostridium difficile, Escherichia coli, and even Bacillus anthracis. These proteins can prevent toxins from binding to gut cells, reduce inflammation, and support the integrity of the gut barrier. Some strains also produce antimicrobial compounds that directly attack harmful bacteria and diminish their toxic effects.

Pathogens- Any disease-causing microscopic organisms, such as dangerous bacteria, viruses, fungi, or parasites.

Enzymes- Specialized biological proteins that act like natural spark plugs, rapidly speeding up chemical reactions and processes inside living cells.

Inflammation- The body's natural defense reaction to injury or infection, causing redness, swelling, warmth, and pain as it tries to heal itself.

Gut barrier- A highly organized, protective cellular wall lining the intestines that lets healthy nutrients pass through while locking out dangerous germs and toxins.

Antimicrobial compounds- Protective substances manufactured by cells or friendly microbes that directly weaken, stop the growth of, or destroy competing, harmful germs.

Immune Response

Saccharomyces boulardii supports the immune system by helping to maintain its balance. It can regulate immune responses during infections and assist the body in fighting off harmful microbes. It modulates the immune system by inhibiting excessive pro-inflammatory responses, thereby reducing inflammation. Additionally, it helps regulate the production of anti-inflammatory signals, promoting a balanced immune reaction.

Immune system- The body's intricate, built-in defense network of cells, tissues, and organs that constantly works to protect you against illnesses and infections.

Pro-inflammatory responses- The body’s active alerting system that releases chemical messengers to ramp up swelling, heat, and defensive activity at an infection site.

Anti-inflammatory signals- Beneficial biochemical messages released by cells to calm down swelling, soothe irritated tissues, and help the body heal.

Trophic Effects

Saccharomyces boulardii helps maintain gut health by enhancing the activity of enzymes involved in food digestion and nutrient absorption. It supports the repair and regeneration of gut cells, particularly after damage, and aids in the breakdown of sugars such as lactose, helping to alleviate symptoms of lactose intolerance. This probiotic also increases the production of natural compounds known as short-chain fatty acids, which strengthen the gut lining, reduce inflammation, and inhibit the growth of harmful bacteria. Additionally, it releases beneficial substances that protect gut cells, improve digestion, and support a robust immune response.

Lactose- A natural, unique sugar found exclusively in milk and dairy products that requires specific digestive enzymes to break down properly.

Lactose intolerance- A common digestive issue where the body cannot fully break down lactose, leading to bloating, gas, and cramps after eating dairy.

Short-chain fatty acids- Beneficial organic acids produced when friendly gut microbes ferment dietary fiber; they fuel gut cells and help manage body-wide inflammation.

Gut lining- The continuous, delicate inner layer of tissue that coats your stomach and intestines, acting as a shield and absorbing nutrients.

Anti-toxin effect

S. boulardii can neutralize toxins produced by pathogens either by blocking their receptor sites or by directly degrading the toxins themselves. One of its most fascinating properties is the production of serine protease, an enzyme responsible for breaking down Clostridium difficile toxins. Various studies have also shown that S. boulardii can reduce the effects of cholera toxin through a specific protein that it naturally produces.

Receptor sites- Special molecular landing docks on the surface of cells where hormones, nutrients, or even viruses and bacteria can lock in to trigger a reaction.

Serine protease- A specific group of powerful enzymes that break down proteins, which some friendly yeasts use to neutralize harmful toxins made by dangerous bacteria.

Industrial Application

Saccharomyces boulardii has various industrial applications. It is used as a starter culture in the dairy industry and is incorporated into products such as yogurt, kefir, milk, cheese, and certain types of beer. In one interesting study involving goat yogurt processing, S. boulardii was supplemented after the addition of the starter culture. The presence of this yeast improved the survival rate of lactic acid bacteria and enhanced product stability without affecting the taste.

Did you know?

Yeasts like Saccharomyces cerevisiaestrains are popularly known for their baking and brewing properties. These were mostly associated with applications in the food industry rather than health benefits. However, the discovery of Saccharomyces boulardii, a close relative of Saccharomyces cerevisiae, by Henri Boulard, unravelled its potential health benefits in 1920. From then on, there has been profound interest in Saccharomyces boulardii as a probiotic agent. S. boulardiiCNCM I-745 was the first yeast probiotic that was studied for clinical disorders in humans.

Microbial Profile

Shape	oval or spherical cell
Size	2–3 µm width and 2.5–10.5 µm length
Optimal temperature	37℃
Optimal pH	2
Tolerance	Bile salts
Spore formation	No spore formation

Taxonomic Classification

Domain	Eukaryota
Kingdom	Fungi
Division	Ascomycota
Class	Saccharomycetes
Order	Saccharomycetales
Family	Saccharomycetaceae
Genus	Saccharomyces
Species	Saccharomyces boulardii

-Varsha V

Reference

McCullough, M. J., Clemons, K. V., McCusker, J. H., & Stevens, D. A. (1998). Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). Journal of clinical microbiology, 36(9), 2613–2617. https://doi.org/10.1128/JCM.36.9.2613-2617.1998

Pais, P., Almeida, V., Yılmaz, M., & Teixeira, M. C. (2020). Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. Journal of fungi (Basel, Switzerland), 6(2), 78. https://doi.org/10.3390/jof6020078

Ansari, F., Alian Samakkhah, S., Bahadori, A., Jafari, S. M., Ziaee, M., Khodayari, M. T., & Pourjafar, H. (2021). Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition, 63(4), 457–485. https://doi.org/10.1080/10408398.2021.1949577

Tomičić, Z., Šarić, L., & Tomičić, R. (2024). Novel Insights in the Application of Probiotic Yeast Saccharomyces boulardii in Dairy Products and Health Promotion. Foods, 13(18), 2866. https://doi.org/10.3390/foods13182866

Mcfarland, L. V. (2017). The Microbiota in Gastrointestinal Pathophysiology Common Organisms and Probiotics: Saccharomyces boulardii. In The Microbiota in Gastrointestinal Pathophysiology. https://doi.org/10.1016/B978-0-12-804024-9/00018-5

Gopalan, S., Ganapathy, S., Mitra, M., Neha, Kumar Joshi, D., Veligandla, K. C., Rathod, R., & Kotak, B. P. (2023). Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review. Cureus, 15(10), e46314. https://doi.org/10.7759/cureus.46314

SACCHAROMYCES BOULARDII

PROBIOTICS

Frequently Asked Questions

How was Saccharomyces boulardii originally discovered by French microbiologist Henri Boulard?

In 1920, Henri Boulard isolated this unique yeast from tropical fruit skins during a severe cholera outbreak in Indochina. He noticed that local populations who drank tea made from lychee and mangosteen skins remained completely unaffected by the disease.

By what specific biochemical mechanism does Saccharomyces boulardii neutralize dangerous bacterial toxins?

The yeast produces a powerful enzyme called serine protease that directly breaks down dangerous Clostridium difficile toxins in the gut. It also releases unique proteins that block cellular receptor sites and successfully diminish the toxic effects of cholera.

How does Saccharomyces boulardii actively support food digestion and alleviate lactose intolerance symptoms?

It enhances digestive enzyme activity to improve nutrient absorption and actively assists in the structural breakdown of dairy sugars. Furthermore, it increases short-chain fatty acid production to protect gut cells and strengthen the intestinal lining.

What did research reveal about using Saccharomyces boulardii as a supplementary culture in goat yogurt processing?

Adding this yeast after the primary starter culture successfully boosted the overall survival rate and stability of beneficial lactic acid bacteria. This industrial processing method significantly enhanced the product's shelf-life dynamics without altering its consumer taste profile.

What historical significance does the specific strain Saccharomyces boulardii CNCM I-745 hold in probiotic research?

While classic yeasts were historically linked to industrial baking and brewing, this strain completely shifted the focus toward human health. It proudly stands as the very first recorded yeast probiotic ever evaluated for treating clinical disorders in humans.

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.

Visit Site